| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |